Evidence map›Paper›PMID 41827287›Full record

ArticleJournal of clinical medicine2026

Dual Evaluation of

Johann Röhrl, Maria-Riera Piqué-Borràs, Mónica Mennet-von Eiff, Gerald Künstle

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johann RöhrlR&D Pharma, Weleda AG, 4144 Arlesheim, Switzerland.ORCID 0009-0003-2238-5351
Maria-Riera Piqué-BorràsR&D Pharma, Weleda AG, 4144 Arlesheim, Switzerland.ORCID 0009-0003-6340-2031
Mónica Mennet-von EiffR&D Pharma, Weleda AG, 4144 Arlesheim, Switzerland.
Gerald KünstleR&D Pharma, Weleda AG, 4144 Arlesheim, Switzerland.ORCID 0009-0003-5606-5487

Funding

Weleda AG N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidant activitydry eye disease (DED)hyaluronic acid (HA)mallow flower extractmalva extractMalva sylvestrisoxidative stressreactive oxygen species (ROS)refractive indexsurface tension

Identifiers

PMID41827287
PMCPMC12985523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.